• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE Back to Search Results
Model Number ESS305
Device Problems Break (1069); Difficult to Remove (1528); Use of Device Problem (1670)
Patient Problem No Information (3190)
Event Type  malfunction  
Event Description
This spontaneous case was reported by a consumer and describes the occurrence of device breakage ("a lot of operations are failures due to broken inserts because of the lack of a protocol for removal") and complication of device removal ("a lot of operations are failures due to broken inserts because of the lack of a protocol for removal") in unknown number of female patients who had essure inserted.Other product or product use issues identified: circumstance or information capable of leading to device use error "a lot of operations are failures due to broken inserts because of the lack of a protocol for removal".On an unknown date, the patients had essure inserted.On an unknown date, the patients experienced device breakage and complication of device removal.At the time of the report, the device breakage and complication of device removal outcome was unknown.The reporter considered complication of device removal and device breakage to be related to essure.The reporter commented an article on a blog.The list of device similar events contains essure reports received by bayer and older cases received by conceptus coded with the same meddra preferred term.In this particular case a search in the database was performed on 12-jul-2017 for the following meddra preferred term: device breakage.The analysis in the global safety database revealed 1652 cases.Bayer is closely monitoring the benefit-risk profile of essure.A recent cumulative review of all available data on essure has not yielded any new safety signal with regard to this meddra pt.Further company follow-up with the consumer is not possible.Other reportable incident.No lot number or sample available for investigation.There is no evidence that a device-related defect or malfunction caused a death or serious injury.If additional information becomes available it will be provided on a supplemental report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESSURE
Type of Device
TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE
Manufacturer (Section D)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM  13353
Manufacturer (Section G)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM   13353
Manufacturer Contact
k. shaw lamberson
100 bayer blvd, p.o. box 915
whippany, NJ 07981-0915
MDR Report Key6728831
MDR Text Key80821001
Report Number2951250-2017-02574
Device Sequence Number1
Product Code HHS
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P020014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign,other
Reporter Occupation Other
Type of Report Initial
Report Date 07/20/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/20/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberESS305
Was the Report Sent to FDA? No
Date Manufacturer Received07/10/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-